Index
RUT
Market Cap
875.66M
Enterprise Value
757.26M
Income
-40.88M
Sales
186.45M
Book/sh
8.77
Cash/sh
7.83
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
738
IPO
Jan 31, 2005
P/E
-
Forward P/E
-
PEG
-
P/S
4.70
P/B
1.97
P/C
2.21
P/FCF
-
EV/EBITDA
-
EV/Sales
4.06
Quick Ratio
1.98
Current Ratio
2.08
Debt/Eq
0.47
LT Debt/Eq
0.09
Option/Short
Yes / Yes
EPS (ttm)
-0.82
EPS next Y
-0.64
EPS next Q
-0.18
EPS this Y
-156.31%
EPS next Y
18.20%
EPS next 5Y
-
EPS past 3/5Y
-0.23% 13.68%
Sales past 3/5Y
-9.45% 17.49%
EPS Y/Y TTM
17.42%
Sales Y/Y TTM
-8.01%
EPS Q/Q
24.23%
Sales Q/Q
7.74%
Insider Own
4.39%
Insider Trans
-10.34%
Inst Own
90.20%
Inst Trans
3.31%
ROA
-4.30%
ROE
-6.54%
ROIC
-6.17%
Gross Margin
40.16%
Oper. Margin
-21.25%
Profit Margin
-21.92%
SMA20
0.39%
SMA50
6.25%
SMA200
35.68%
Trades
Shs Outstand
50.65M
Shs Float
48.43M
52W High
18.36 -5.83%
52W Low
7.61 127.18%
Volatility
4.37% 3.57%
ATR (14)
0.60
RSI (14)
54.74
Beta
1.90
Rel Volume
0.38
Avg Volume
641.16K
Volume
61,481
Perf Week
-0.81%
Perf Month
13.22%
Perf Quarter
10.05%
Perf Half Y
78.79%
Perf YTD
80.09%
Perf Year
73.93%
Perf 3Y
42.29%
Perf 5Y
-73.64%
Perf 10Y
757.83%
Prev Close
16.90
Price
17.29
Change %
2.30%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-06-25 Upgrade
Leerink Partners
Market Perform → Outperform
$16
Aug-06-25 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
Jul-22-25 Resumed
Stephens
Overweight
$13
Mar-24-25 Upgrade
UBS
Neutral → Buy
$10
Dec-19-24 Initiated
Guggenheim
Buy
$11
Aug-07-24 Downgrade
Jefferies
Buy → Hold
$20 → $8
Jul-31-24 Upgrade
B. Riley Securities
Neutral → Buy
$19 → $15
May-03-24 Downgrade
B. Riley Securities
Buy → Neutral
$22 → $19
Apr-04-24 Resumed
Jefferies
Buy
$17 → $21
Mar-13-24 Reiterated
Needham
Buy
$19 → $18
Aug-17-23 Initiated
Morgan Stanley
Equal-Weight
$16
Aug-10-23 Downgrade
Stephens
Overweight → Equal-Weight
$15
Jul-18-23 Downgrade
UBS
Buy → Neutral
$28 → $17
Jul-17-23 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Jul-13-23 Downgrade
SVB Securities
Outperform → Market Perform
$30 → $10
Jan-19-22 Upgrade
ROTH Capital
Neutral → Buy
$90
Nov-05-21 Downgrade
ROTH Capital
Buy → Neutral
$78 → $90
Oct-19-21 Resumed
B. Riley Securities
Buy
$81
Jul-16-21 Initiated
BTIG Research
Buy
$80
Mar-15-21 Initiated
UBS
Buy
$84
Show Previous Ratings
Aug-07-26 08:30AM
01:05AM
Aug-06-26 04:05PM
Jul-23-26 08:00AM
Jun-25-26 08:00AM
08:23PM
Loading…
May-04-26 08:23PM
04:05PM
Apr-20-26 04:05PM
Mar-04-26 08:30AM
12:00AM
Mar-03-26 07:02PM
05:25PM
04:05PM
Feb-18-26 08:10AM
Feb-17-26 08:00AM
08:30AM
Loading…
Feb-11-26 08:30AM
08:16AM
Nov-05-25 12:09AM
Nov-04-25 05:50PM
04:05PM
Nov-03-25 08:01AM
Oct-30-25 08:30AM
Oct-21-25 08:00AM
Oct-17-25 04:09AM
Oct-07-25 08:30AM
Oct-01-25 08:30AM
Aug-06-25 03:32AM
Aug-05-25 06:35PM
04:19PM
Aug-04-25 05:55PM
10:02AM
Loading…
10:02AM
Jul-31-25 05:25PM
10:00AM
Jul-29-25 10:00AM
Jul-25-25 09:55AM
Jul-22-25 08:00AM
Jul-08-25 08:00AM
07:45AM
Jul-04-25 12:00PM
Jun-27-25 12:00PM
Jun-12-25 08:00AM
May-28-25 09:55AM
May-12-25 09:55AM
May-08-25 03:34AM
May-07-25 07:15PM
07:15PM
05:20PM
04:05PM
May-06-25 09:35AM
Apr-30-25 10:01AM
Apr-24-25 08:30AM
Apr-10-25 10:39AM
Apr-04-25 06:03AM
Mar-31-25 03:11PM
09:06AM
08:09AM
Mar-26-25 09:15AM
Mar-18-25 07:59PM
Mar-13-25 07:28AM
Mar-12-25 08:30AM
Mar-05-25 02:10AM
Mar-04-25 05:35PM
04:10PM
Mar-03-25 07:18AM
Feb-18-25 08:30AM
Jan-21-25 08:30AM
Jan-14-25 08:30AM
Jan-06-25 08:30AM
Nov-12-24 08:30AM
Nov-08-24 04:03PM
Nov-07-24 05:55PM
04:05PM
Nov-06-24 07:37AM
Oct-31-24 10:01AM
Oct-29-24 08:30AM
Oct-22-24 08:30AM
Oct-21-24 08:30AM
Oct-15-24 08:30AM
Oct-07-24 08:30AM
Sep-25-24 08:30AM
Sep-09-24 05:28AM
Aug-19-24 03:27AM
Aug-06-24 07:00PM
04:15PM
04:05PM
Jul-23-24 08:30AM
Jul-12-24 02:46AM
Jul-09-24 09:35AM
Jun-20-24 08:30AM
May-17-24 02:33AM
May-08-24 02:54PM
04:03AM
May-07-24 09:56PM
06:18PM
04:08PM
May-03-24 10:12AM
06:41AM
Apr-30-24 08:30AM
Apr-25-24 10:02AM
Mar-13-24 09:16AM
Cryoport, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
SHELTON JERRELL President, CEO Aug 11 '26 Sale 14.91 28,800 429,385 1,201,814 Aug 11 06:49 PM JERRELL W SHELTON Director Aug 11 '26 Proposed Sale 14.82 28,800 426,816 Aug 11 04:31 PM ZECCHINI EDWARD J Chief Digital and Tech Officer Jun 11 '26 Option Exercise 4.80 33,600 161,280 143,319 Jun 12 06:38 PM ZECCHINI EDWARD J Chief Digital and Tech Officer Jun 10 '26 Option Exercise 4.80 1,400 6,720 111,119 Jun 12 06:38 PM ZECCHINI EDWARD J Chief Digital and Tech Officer Jun 11 '26 Sale 14.47 33,600 486,239 109,719 Jun 12 06:38 PM ZECCHINI EDWARD J Chief Digital and Tech Officer Jun 10 '26 Sale 15.23 1,400 21,324 109,719 Jun 12 06:38 PM EDWARD ZECCHINI Officer Jun 11 '26 Proposed Sale 14.47 33,600 486,239 Jun 11 04:09 PM EDWARD ZECCHINI Officer Jun 10 '26 Proposed Sale 15.23 1,400 21,324 Jun 10 04:15 PM STEFANOVICH ROBERT Chief Financial Officer Jun 04 '26 Sale 16.27 169,427 2,756,984 109,850 Jun 08 09:11 PM Mandalam Ramkumar Director Jun 08 '26 Sale 15.44 23,214 358,452 67,894 Jun 08 09:05 PM RAMKUMAR MANDALAM Director Jun 08 '26 Proposed Sale 15.44 23,214 358,452 Jun 08 04:17 PM STEFANOVICH ROBERT Officer Jun 04 '26 Proposed Sale 16.50 169,427 2,795,546 Jun 03 04:35 PM SHELTON JERRELL President, CEO Apr 21 '26 Option Exercise 1.87 104,007 194,493 1,230,614 Apr 23 08:00 PM SHELTON JERRELL President, CEO Apr 06 '26 Option Exercise 1.87 50,000 93,500 1,126,607 Apr 08 06:32 PM STEFANOVICH ROBERT Chief Financial Officer Mar 23 '26 Sale 8.18 1,094 8,949 279,277 Mar 25 08:01 PM SHELTON JERRELL President, CEO Mar 23 '26 Option Exercise 1.87 25,000 46,750 1,076,607 Mar 25 08:00 PM SHELTON JERRELL President, CEO Mar 23 '26 Sale 8.18 2,894 23,673 1,051,607 Mar 25 08:00 PM Sawicki Mark W Chief Scientific Officer Mar 23 '26 Sale 8.18 1,341 10,969 102,356 Mar 25 08:00 PM ZECCHINI EDWARD J See Remarks Mar 16 '26 Sale 8.00 2,014 16,112 109,719 Mar 17 08:01 PM SHELTON JERRELL President, CEO Mar 16 '26 Sale 8.00 7,918 63,344 1,054,501 Mar 17 08:00 PM Sawicki Mark W Chief Scientific Officer Mar 16 '26 Sale 8.00 3,235 25,880 103,697 Mar 17 08:00 PM STEFANOVICH ROBERT Chief Financial Officer Mar 12 '26 Option Exercise 1.87 87,188 163,042 294,401 Mar 16 09:35 PM STEFANOVICH ROBERT Chief Financial Officer Mar 12 '26 Sale 7.76 38,700 300,386 255,701 Mar 16 09:35 PM STEFANOVICH ROBERT Chief Financial Officer Mar 16 '26 Sale 8.00 2,743 21,944 280,371 Mar 16 09:35 PM ROBERT S. STEFANOVICH Officer Mar 12 '26 Proposed Sale 7.76 38,700 300,386 Mar 12 04:17 PM Mandalam Ramkumar Director Dec 10 '25 Sale 9.99 11,570 115,540 80,758 Dec 12 05:30 PM RAMKUMAR MANDALAM Director Dec 10 '25 Proposed Sale 9.99 11,570 115,540 Dec 10 04:10 PM